Navigation Links
New gene variants associated with glucose, insulin levels, some with diabetes risk

A major international study with leadership from Massachusetts General Hospital (MGH) researchers has identified 10 new gene variants associated with blood sugar or insulin levels. Two of these novel variants and three that earlier studies associated with glucose levels were also found to increase the risk of type 2 diabetes. Along with a related study from members of the same research consortium, associating additional genetic variants with the metabolic response to a sugary meal, the report will appear in Nature Genetics and has been released online.

"Only four gene variants had previously been associated with glucose metabolism, and just one of them was known to affect type 2 diabetes. With more genes identified, we can see patterns emerge," says Jose Florez, MD, PhD, of the MGH Diabetes Unit and the Center for Human Genetic Research, co-lead author of the report. "Finding these new pathways can help us better undertand how glucose is regulated, distinguish between normal and pathological glucose variations and develop potential new therapies for type 2 diabetes."

Both studies were conducted by the Meta-Analyses of Glucose and Insulin-related Traits Consortium (MAGIC), a collaboration among researchers from centers in the U.S., Canada, Europe and Australia that analyzed gene samples from 54 previous studies involving more than 122,000 individuals of European descent. The study co-led by MGH scientists along with colleagues from Boston University, University of Cambridge, University of Oxford and the University of Michigan began by analyzing about 2.5 million gene variations (called SNPs) from 21 genome-wide searches for variants associated with glucose and insulin regulation in more than 46,000 nondiabetic participants. The 25 most promising SNPs from the first phase were then tested in more than 76,000 nondiabetic participants in 33 other studies, leading to new associations of nine SNPs with fasting glucose levels and one with fasting insulin and with a measure of insulin resistance.

Analysis of genetic data from additional studies involving both diabetic and nondiabetic participants found that five glucose-level-associated variants two of those newly identified and three discovered in previous studies were also shown to raise type 2 diabetes risk. Most of the diabetes-associated variants appear to act through their impact on insulin secretion by the pancreatic beta cells and not by insulin resistance, which suggests, the authors note, that environmental factors such as diet, lifestyle and obesity may play a larger role in insulin resistance than in insulin secretion.

"The fact that not all genes involved with raising glucose levels increase diabetes risk tells us that it's not the mere fact of raising glucose that's important but rather how glucose is raised. It's one thing to increase glucose slightly within the normal range and quite another to affect a pathway that eventually leads to progressive glucose elevation, beta-cell failure or insulin resistance in other words type 2 diabetes, " says Florez, who is an assistant professor of Medicine at Harvard Medical School. "We've still only identified about 10 percent of the genetic contribution to glucose levels in nondiabetic individuals, so we need to investigate the impact of other, possibly more complex or rare forms of gene variation, along with the role of gene-environment interactions, in causing type 2 diabetes. Performing similar studies in non-European populations will also be essential."


Contact: Sue McGreevey
Massachusetts General Hospital

Related biology news :

1. Identification of genetic variants affecting age at menopause could help improve fertility treatment
2. Common gene variants influence risk factor for sudden cardiac death
3. Common gene variants increase risk of hypertension, may lead to new therapies
4. International study identifies gene variants associated with early heart attack
5. Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimers
6. New gene variants present opportunities in nutrigenomics
7. Study identifies genetic variants giving rise to differences in metabolism
8. Interaction between gene variants may alter brain function in schizophrenia
9. Genetic variants of USF1 are associated with the increased risk for cardiovascular disease
10. New genetic variants associated with lipid levels, risk for coronary artery disease
11. Scientists associate 6 new genetic variants with heart disease risk factor
Post Your Comments:
(Date:10/8/2015)... , October 8, 2015 ... the "Company"), a biometric authentication company focused on ... the Wocket® smart wallet announces that revenues for ... approximately $410,000 compared with $113,00 for the three ... 9 months ended September 30, 2015 were approximately ...
(Date:10/5/2015)... , October 5, 2015 ... company update for NXT-ID, Inc. (NASDAQ: NXTD ), ... commerce market. --> ) ... Inc. (NASDAQ: NXTD ), a biometric authentication company ... SoundView Technology Group ( ) ...
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... JACKSONVILLE, Florida , October 13, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, will be a featured presenting company ... at the Wyndham Grand Hotel in ... --> TapImmune, Inc. (TPIV), a clinical-stage immunotherapy ...
(Date:10/13/2015)... , Oct. 13, 2015  Generex Biotechnology Corporation ( ... into a non-binding Letter of Intent (LOI) with MediTemp Ltd. ... developed a proprietary cooling technology designed to improve sperm quality ... the United States and three million men in ... and 44 diagnosed as infertile.  For 42% of those men, ...
(Date:10/13/2015)... ... 13, 2015 , ... Clinovo recently appointed Jeff Parr and Ed Donaldson to ... data solutions business. , Jeff Parr has spent the past decade providing quality management ... Thermo Fisher, and Ab Sciex to name a few. He is based in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Proove ... to announce their partnership with the Keck Medicine of the University of ... , The T.R.O.J.A.N. Study (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and ...
Breaking Biology Technology: